CSA MEDICAL
CSA Medical provides cryotherapy systems. It offers CryoSpray Ablation system, which enables the physicians to freeze, destroy, and remove unwanted tissues, as well as transports liquid nitrogen that is passed through a standard endoscope. CSA Medical was formerly known as Crymed Technologies and changed its name to CSA Medical in April 2006. The company was incorporated in 1993 and is based in Lutherville Timonium, Maryland.
CSA MEDICAL
Social Links:
Industry:
Biotechnology Health Care Medical Device
Founded:
1993-01-01
Address:
Lutherville Timonium, Maryland, United States
Country:
United States
Website Url:
http://www.rejuvenair.com
Total Employee:
51+
Status:
Active
Contact:
4438362393
Total Funding:
106.05 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 AWS Global Accelerator Formidable Pro Form
Similar Organizations
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Venture Round - CSA Medical
Intersouth Partners
Intersouth Partners investment in Venture Round - CSA Medical
Ascension Ventures
Ascension Ventures investment in Venture Round - CSA Medical
SV Health Investors
SV Health Investors investment in Venture Round - CSA Medical
SV Health Investors
SV Health Investors investment in Debt Financing - CSA Medical
First Analysis
First Analysis investment in Series C - CSA Medical
Rose Park Advisors
Rose Park Advisors investment in Series C - CSA Medical
SV Health Investors
SV Health Investors investment in Series C - CSA Medical
Ascension Ventures
Ascension Ventures investment in Series C - CSA Medical
Blue Heron Capital
Blue Heron Capital investment in Series C - CSA Medical
Official Site Inspections
http://www.rejuvenair.com
- Host name: ec2-3-134-65-21.us-east-2.compute.amazonaws.com
- IP address: 3.134.65.21
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "CSA Medical"
RejuvenAir Company Profile | Management and Employees List
RejuvenAir Profile and History CSA Medical, Inc. develops and manufactures a proprietary interventional spray cryotherapy technology platform utilizing unique properties of liquid …See details»
CSA Medical - Crunchbase Company Profile & Funding
Headquarters Regions Greater Baltimore-Maryland Area, East Coast, Southern US Founded Date 1993 Founders Steve Schaefer Operating Status Active Last Funding Type Series D Legal Name CSA Medical, Inc. Company Type For …See details»
RejuvenAir - News about Rejuvenair Chronic Bronchitis treatment
Nov 11, 2020 News about Rejuvenair Chronic Bronchitis treatment. Learn more about the RejuvenAir System and the SPRAY-CB Study that is now recruioting in the USA.See details»
RejuvenAir Company Profile - Office Locations, Competitors, …
RejuvenAir has 5 employees at their 1 location and $103.1 m in total funding,. See insights on RejuvenAir including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
RejuvenAir Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for RejuvenAir. Use the PitchBook Platform to explore the full profile.See details»
RejuvenAir - Company Profile - Tracxn
Nov 27, 2024 RejuvenAir - Developer of a cryosurgical device for chronic bronchitis and COPD. Raised a total funding of $171M over 14 rounds from 9 investors.See details»
CSA Medical Raises $53 Million in Series D Financing
Sep 9, 2024 CSA Medical Inc. today announced the completion of an oversubscribed $53 million Series D preferred stock equity financing.See details»
RejuvenAir’s Competitors, Revenue, Number of Employees, …
RejuvenAir’s Profile, Revenue and Employees. RejuvenAir is a Massachusetts-based medical device company that designs and markets cryosurgical devices for the treatment of bronchitis. …See details»
CSA Medical raises $53m to commercialise bronchitis cryotherapy
Sep 9, 2024 CSA Medical has raised $53m in Series D stock equity financing to advance the commercialisation of its RejuvenAir cryotherapy system for treating chronic bronchitis. The …See details»
Trial testing RejuvenAir device in chronic bronchitis is …
Jul 15, 2024 Enrollment is complete for a clinical trial of RejuvenAir, a device that uses a liquid nitrogen spray to treat COPD with chronic bronchitis.See details»
Cryotherapy Spray For COPD Approved FDA - Emphysema …
The RejuvenAir System radial spray cryotherapy is for conditions associated with abnormal bronchial function, such as chronic bronchitis. “We are eager to begin this pivotal trial and …See details»
First Randomized Controlled Study with RejuvenAir for Chronic ...
Sep 6, 2022 The RejuvenAir System is designed to address the underlying cause of Chronic Bronchitis, the damaged cilia and mucus-producing goblet cells lining the airways and enable …See details»
RejuvenAir - Raised $171M Funding from 9 investors - Tracxn
Dec 6, 2024 RejuvenAir has raised a total funding of $171M over 14 rounds from 9 investors. Investors include First Analysis, SV Health Investors and 7 others. Their latest funding round …See details»
REJUVENAIR - Company Profile & Staff Directory | ContactOut
REJUVENAIR, the smart air purification system, is here to protect indoor air quality in business environments. The patent-pending technology uses military grade UVC and HEPA filters, …See details»
First Randomized Controlled Study with RejuvenAir® for Chronic ...
Sep 6, 2022 The RejuvenAir System is designed to address the underlying cause of Chronic Bronchitis, the damaged cilia and mucus-producing goblet cells lining the airways and enable …See details»
CSA Medical Announces New Scientific Data Utilizing Metered …
Sep 16, 2024 The RejuvenAir System is a medical device therapy targeting the underlying chronic cough, dysfunctional mucus production and clearance in Chronic Bronchitis. The …See details»
Rejuvenair System Granted CE Mark for COPD With Chronic …
Dec 10, 2019 RejuvenAir System, a cryosurgical device developed by CSA Medical, has been granted CE Mark approval for the treatment of COPD with chronic bronchitis.See details»
CSA Medical Announces Completion of Enrollment in ... - RejuvenAir
May 13, 2021 All subjects have been enrolled in the RejuvenAir System study Characterizing the Mechanism of Action of Metered Cryospray for the Treatment of Patients with Chronic …See details»
CSA Medical wins CE Mark approval for RejuvenAir System
Dec 4, 2019 CSA Medical announced this week that it won CE Mark approval for its RejuvenAir system for treating chronic obstructive pulmonary disease (COPD) with chronic bronchitis (CB).See details»